1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page explicitly states 'Grant Submission Currently Closed'. When open, applications are received and reviewed on a rolling basis with no fixed deadline.
Research Grants (Opioid-sparing or mitigating pain management strategies) is sponsored by Rothman Opioid Foundation. The Rothman Opioid Foundation supports research around the opioid crisis, including opioid-sparing or mitigating pain management strategies, social, psychological, and behavioral determinants of substance abuse, and evaluations of alternative pain solutions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Key questions and narrative sections extracted from the solicitation.
Study title
Research question
Project narrative
IRB proof
Budget with justification
CV
Faculty support letter (if applicable)
Biosketches for co-investigators
According to the current listing, eligibility includes: An academic or research professional with an academic appointment, specializing in the areas of opioid abuse, pain management, substance abuse, psychology, and public health. Graduate students or professional students/resident physicians are also eligible to apply with a faculty mentor. Confirm the full requirements in the official notice before applying.
The current listing shows up to $10,000 per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Research Grants (Opioid-sparing or mitigating pain management strategies) is funded by Rothman Opioid Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe FY2026 COPS Anti-Heroin Task Force program funds statewide opioid-interdiction task forces with awards up to $4 million and no local match. But eligibility is narrower than most agencies assume, and there are two deadlines — July 23 and July 29. Here's the deep dive on who qualifies and how to build a competitive application.
Read articleThe RCORP-Planning and RCORP-Impact programs offer $100K to $750K/year for rural communities fighting substance use disorder. Applications close May 29 and June 1. A strategic guide for first-time and returning applicants.
Read article